BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi Y, Zhou Y. The role of surgery in the treatment of gastric cancer. J Surg Oncol. 2010;101:687-692. [PMID: 20512944 DOI: 10.1002/jso.21455] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, He C, Wang X, Wang H, Nan G, Fang L. RETRACTED ARTICLE: MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:3163-71. [DOI: 10.1080/21691401.2019.1642903] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
2 Xia J, Guo X, Yan J, Deng K. The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol. 2014;140:1451-1456. [PMID: 24659367 DOI: 10.1007/s00432-014-1649-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
3 Huang SF, Lin JC, Shiau AC, Chen YC, Li MH, Tsai JT, Liu WH. Optimal tumor coverage with different beam energies by IMRT, VMAT and TOMO: Effects on patients with proximal gastric cancer. Medicine (Baltimore) 2020;99:e23328. [PMID: 33217871 DOI: 10.1097/MD.0000000000023328] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhang X, Zhang X, Sun B, Lu H, Wang D, Yuan X, Huang Z. Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer. Oncol Lett 2014;8:1745-50. [PMID: 25202403 DOI: 10.3892/ol.2014.2410] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
5 Zhou C, Pan R, Li B, Huang T, Zhao J, Ying J, Duan S. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60. Future Oncol 2019;15:1279-89. [PMID: 30924352 DOI: 10.2217/fon-2018-0674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Yu J, Cao X, Zheng Y, Yan L, Wang J. Abnormal expression of miR‑133a in patients with acute myocardial infarction following radical surgery for gastric cancer and the underlying mechanism. Mol Med Rep 2018;18:5023-9. [PMID: 30320356 DOI: 10.3892/mmr.2018.9541] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Dong L, Hui L. HOTAIR Promotes Proliferation, Migration, and Invasion of Ovarian Cancer SKOV3 Cells Through Regulating PIK3R3. Med Sci Monit 2016;22:325-31. [PMID: 26826873 DOI: 10.12659/msm.894913] [Cited by in Crossref: 45] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
8 Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, Kong R, Xia R, Lu KH, Li JH. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92. [PMID: 24775712 DOI: 10.1186/1476-4598-13-92] [Cited by in Crossref: 568] [Cited by in F6Publishing: 598] [Article Influence: 71.0] [Reference Citation Analysis]
9 Molnár FT, Horváth OP, Farkas L, Gerlinger I, Pajor L, Kelemen D, Kalmár Nagy K, Tizedes G, Pavlovics G, Bódis J, Gocze P, Szekeres G. [From the surgical field to the microscope. A new tool to identify the lymph node specimens in oncologic surgery]. Magy Seb 2011;64:6-11. [PMID: 21330257 DOI: 10.1556/MaSeb.64.2011.1.2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Li Y, Wang Y, Li D, Zhang Y, Zhao T, Li C. Procaine is a specific DNA methylation inhibitor with anti‐tumor effect for human gastric cancer. J Cell Biochem 2018;119:2440-9. [DOI: 10.1002/jcb.26407] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
11 Amini M, Foroughi K, Talebi F, Aghagolzade Haji H, Kamali F, Jandaghi P, Hoheisel JD, Manoochehri M. GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond. J Cell Physiol 2019;234:15320-9. [DOI: 10.1002/jcp.28179] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4:279-294. [PMID: 22690664 DOI: 10.2217/epi.12.22] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
13 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
14 Bencini L, Marchet A, Alfieri S, Rosa F, Verlato G, Marrelli D, Roviello F, Pacelli F, Cristadoro L, Taddei A, Farsi M; Italian Research Group for Gastric Cancer (GIRCG). The Cholegas trial: long-term results of prophylactic cholecystectomy during gastrectomy for cancer—a randomized-controlled trial. Gastric Cancer 2019;22:632-9. [DOI: 10.1007/s10120-018-0879-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Gong L, Xia Y, Qian Z, Shi J, Luo J, Song G, Xu J, Ye Z. Overexpression of MYC binding protein promotes invasion and migration in gastric cancer. Oncol Lett 2018;15:5243-9. [PMID: 29552163 DOI: 10.3892/ol.2018.7944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
16 Yao Q, Cao Z, Tu C, Zhao Y, Liu H, Zhang S. MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett. 2013;335:219-224. [PMID: 23435376 DOI: 10.1016/j.canlet.2013.02.031] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 7.7] [Reference Citation Analysis]
17 Sheyi R, de la Torre BG, Albericio F. Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate. Pharmaceutics 2022;14:396. [DOI: 10.3390/pharmaceutics14020396] [Reference Citation Analysis]
18 Shi J, Gong L, Chen L, Luo J, Song G, Xu J, Lv Z, Tao H, Xia Y, Ye Z. miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-β2. Anat Rec (Hoboken) 2019;302:931-40. [PMID: 30737902 DOI: 10.1002/ar.24083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
19 Yue CF, Li LS, Ai L, Deng JK, Guo YM. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2. Exp Cell Res 2021;402:112553. [PMID: 33737068 DOI: 10.1016/j.yexcr.2021.112553] [Reference Citation Analysis]
20 Dong Y, Chen G, Gao M, Tian X. Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer. Gene 2015;563:29-34. [PMID: 25748728 DOI: 10.1016/j.gene.2015.03.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
21 Cao B, Liu C, Yang G. Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway. Biomed Pharmacother 2018;107:185-93. [PMID: 30089248 DOI: 10.1016/j.biopha.2018.06.146] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 7.5] [Reference Citation Analysis]
22 Deng K, Wang H, Guo X, Xia J. The cross talk between long, non-coding RNAs and microRNAs in gastric cancer. Acta Biochim Biophys Sin (Shanghai) 2016;48:111-6. [PMID: 26621794 DOI: 10.1093/abbs/gmv120] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
23 Wang N, She J, Liu W, Shi J, Yang Q, Shi B, Hou P. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients. Cell Cycle 2015;14:732-43. [PMID: 25590580 DOI: 10.1080/15384101.2014.998047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
24 Zhang X, Kang T, Zhang L, Tong Y, Ding W, Chen S. NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide. Oncotarget 2017;8:52735-45. [PMID: 28881766 DOI: 10.18632/oncotarget.17175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
25 Lee YJ, Han ME, Baek SJ, Kim SY, Oh SO. Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells. PLoS One 2015;10:e0131863. [PMID: 26147337 DOI: 10.1371/journal.pone.0131863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
26 Hu H, Xu DH, Huang XX, Zhu CC, Xu J, Zhang ZZ, Zhao G. Keratin17 Promotes Tumor Growth and is Associated with Poor Prognosis in Gastric Cancer. J Cancer 2018;9:346-57. [PMID: 29344281 DOI: 10.7150/jca.19838] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
27 Chang S, He S, Qiu G, Lu J, Wang J, Liu J, Fan L, Zhao W, Che X. MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1. Tumour Biol 2016;37:12141-51. [PMID: 27220320 DOI: 10.1007/s13277-016-5094-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
28 Song P, Lu M, Pu F, Zhang D, Wang B, Zhao Q. Meta-analysis of pylorus-preserving gastrectomy for middle-third early gastric cancer. J Laparoendosc Adv Surg Tech A. 2014;24:718-727. [PMID: 25243417 DOI: 10.1089/lap.2014.0123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 Zhao H, Wang A, Zhang Z. LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465. J Biochem 2020;168:171-81. [PMID: 32211849 DOI: 10.1093/jb/mvaa036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
30 Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu Z, Tang W, Gan L, Sun M, Li J. MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer. Oncotarget 2015;6:25418-28. [PMID: 26317898 DOI: 10.18632/oncotarget.4456] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
31 Kosaka T, Akiyama H, Makino H, Takagawa R, Kimura J, Ono H, Kunisaki C, Endo I. Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol. 2014;73:281-285. [PMID: 24253176 DOI: 10.1007/s00280-013-2350-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
32 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891 [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
33 Yamanaka S, Olaru AV, An F, Luvsanjav D, Jin Z, Agarwal R, Tomuleasa C, Popescu I, Alexandrescu S, Dima S. MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. Dig Liver Dis. 2012;44:589-596. [PMID: 22464652 DOI: 10.1016/j.dld.2012.02.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
34 Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta. 2013;424:53-65. [PMID: 23669186 DOI: 10.1016/j.cca.2013.05.002] [Cited by in Crossref: 201] [Cited by in F6Publishing: 189] [Article Influence: 22.3] [Reference Citation Analysis]
35 Feng Y, Sun T, Yu Y, Gao Y, Wang X, Chen Z. MicroRNA-370 inhibits the proliferation, invasion and EMT of gastric cancer cells by directly targeting PAQR4. J Pharmacol Sci 2018;138:96-106. [PMID: 30322804 DOI: 10.1016/j.jphs.2018.08.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
36 Ni QF, Zhang Y, Yu JW, Hua RH, Wang QH, Zhu JW. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway. Cell Prolif 2020;53:e12630. [PMID: 31713929 DOI: 10.1111/cpr.12630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
37 Ye R, Wei B, Li S, Liu W, Liu J, Qiu L, Wu X, Zhao Z, Li J. Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer. Oncotarget 2017;8:97260-72. [PMID: 29228608 DOI: 10.18632/oncotarget.21919] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
38 Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016; 22(10): 2875-2893 [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
39 Pastrello C, Pasini E, Kotlyar M, Otasek D, Wong S, Sangrar W, Rahmati S, Jurisica I. Integration, visualization and analysis of human interactome. Biochemical and Biophysical Research Communications 2014;445:757-73. [DOI: 10.1016/j.bbrc.2014.01.151] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
40 Lin S, Song S, Sun R, Zhang M, Du Y, Zhang D, Xu W, Wang H. Oncogenic circular RNA Hsa‐circ‐000684 interacts with microRNA‐186 to upregulate ZEB1 in gastric cancer. FASEB j 2020;34:8187-203. [DOI: 10.1096/fj.201903246r] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
41 Qiu T, Wang K, Li X, Jin J. miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP. Exp Ther Med 2018;16:4753-8. [PMID: 30546398 DOI: 10.3892/etm.2018.6813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
42 Mondlane G, Gubanski M, Lind PA, Ureba A, Siegbahn A. Comparison of gastric-cancer radiotherapy performed with volumetric modulated arc therapy or single-field uniform-dose proton therapy. Acta Oncol 2017;56:832-8. [PMID: 28281357 DOI: 10.1080/0284186X.2017.1297536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
43 Wang G, Zhang W, Zhou B, Jin C, Wang Z, Yang Y, Wang Z, Chen Y, Feng X. The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer. Biomed Res Int 2015;2015:741030. [PMID: 26550574 DOI: 10.1155/2015/741030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
44 Gómez A, Pato ML, Bujanda L, Sala N, Companioni O, Cosme Á, Tufano M, Hanly DJ, García N, Sanz-Anquela JM, Gisbert JP, López C, Elizalde JI, Cuatrecasas M, Andreu V, Paules MJ, Martín-Arranz MD, Ortega L, Poves E, Barrio J, Torres MÁ, Muñoz G, Ferrández Á, Ramírez-Lázaro MJ, Lario S, González CA, Esteller M, Berdasco M. Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions. Cancers (Basel) 2021;13:2760. [PMID: 34199386 DOI: 10.3390/cancers13112760] [Reference Citation Analysis]
45 Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Cancer Chemother Pharmacol. 2013;71:789-797. [PMID: 23338051 DOI: 10.1007/s00280-013-2073-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
46 Diaz-Nieto R, Orti-Rodríguez R, Winslet M. Post-surgical chemotherapy versus surgery alone for resectable gastric cancer. Cochrane Database Syst Rev. 2013;9:CD008415. [PMID: 23999923 DOI: 10.1002/14651858.cd008415.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
47 Liang F, Zhang H, Qiu Y, Xu Q, Jian K, Jiang L, Wang F, Lu X. MiR-124-5p Inhibits the Progression of Gastric Cancer by Targeting MIEN1. Technol Cancer Res Treat 2020;19:1533033820979199. [PMID: 33349155 DOI: 10.1177/1533033820979199] [Reference Citation Analysis]
48 Kamphues C, Wittschieber D, Klauschen F, Kasajima A, Dietel M, Schmidt S, Glanemann M, Bahra M, Neuhaus P, Weichert W, Stenzinger A. Prolyl Hydroxylase Domain 2 Protein Is a Strong Prognostic Marker in Human Gastric Cancer. Pathobiology 2012;79:11-7. [DOI: 10.1159/000330170] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
49 Xu M, Zhou K, Wu Y, Wang L, Lu S. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1. Molecular Carcinogenesis 2019;58:577-87. [DOI: 10.1002/mc.22952] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
50 Bernini M, Bencini L, Sacchetti R, Marchet A, Cristadoro L, Pacelli F, Berardi S, Doglietto GB, Rosa F, Verlato G, Cozzaglio L, Bechi P, Marrelli D, Roviello F, Farsi M; Italian Research Group for Gastric Cancer (IRGGC). The Cholegas Study: safety of prophylactic cholecystectomy during gastrectomy for cancer: preliminary results of a multicentric randomized clinical trial. Gastric Cancer 2013;16:370-6. [PMID: 22948317 DOI: 10.1007/s10120-012-0195-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
51 Balluff B, Rauser S, Meding S, Elsner M, Schöne C, Feuchtinger A, Schuhmacher C, Novotny A, Jütting U, Maccarrone G. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol. 2011;179:2720-2729. [PMID: 22015459 DOI: 10.1016/j.ajpath.2011.08.032] [Cited by in Crossref: 109] [Cited by in F6Publishing: 106] [Article Influence: 9.9] [Reference Citation Analysis]
52 Yiwei T, Hua H, Hui G, Mao M, Xiang L. HOTAIR Interacting with MAPK1 Regulates Ovarian Cancer skov3 Cell Proliferation, Migration, and Invasion. Med Sci Monit. 2015;21:1856-1863. [PMID: 26117268 DOI: 10.12659/msm.893528] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
53 Costa WL, Coimbra FJ, Ribeiro HS, Diniz AL, de Godoy AL, Begnami M, Silva MJ, Fanelli MF, Mello CA. Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients. World J Surg Oncol. 2012;10:195. [PMID: 22992263 DOI: 10.1186/1477-7819-10-195] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]